Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Days Sales Outstanding : 66.03 (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Tribute Pharmaceuticals Canada Days Sales Outstanding?

Tribute Pharmaceuticals Canada's average Accounts Receivable for the three months ended in Sep. 2015 was $4.91 Mil. Tribute Pharmaceuticals Canada's Revenue for the three months ended in Sep. 2015 was $6.79 Mil. Hence, Tribute Pharmaceuticals Canada's Days Sales Outstanding for the three months ended in Sep. 2015 was 66.03.

The historical rank and industry rank for Tribute Pharmaceuticals Canada's Days Sales Outstanding or its related term are showing as below:

TBUFF's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 71.68
* Ranked among companies with meaningful Days Sales Outstanding only.

Tribute Pharmaceuticals Canada's Days Sales Outstanding increased from Sep. 2014 (46.01) to Sep. 2015 (66.03).

Tribute Pharmaceuticals Canada Days Sales Outstanding Historical Data

The historical data trend for Tribute Pharmaceuticals Canada's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tribute Pharmaceuticals Canada Days Sales Outstanding Chart

Tribute Pharmaceuticals Canada Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Days Sales Outstanding

Get a 7-Day Free Trial

29.83

59.61

28.73

25.61

30.14

Tribute Pharmaceuticals Canada Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Days Sales Outstanding	Get a 7-Day Free Trial															46.01	34.70	44.64	61.47	66.03

Competitive Comparison of Tribute Pharmaceuticals Canada's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Tribute Pharmaceuticals Canada's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tribute Pharmaceuticals Canada's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tribute Pharmaceuticals Canada's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tribute Pharmaceuticals Canada's Days Sales Outstanding falls into.

Tribute Pharmaceuticals Canada Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tribute Pharmaceuticals Canada's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as

	Days Sales Outstanding (A: Dec. 2014 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2013 )	+	Accounts Receivable (A: Dec. 2014 ))	/	count )	/	Revenue (A: Dec. 2014 )	*	Days in Period
=	( (0.556	+	1.86)	/	2 )	/	14.631	*	365
=	1.208					/	14.631	*	365
=	30.14

Tribute Pharmaceuticals Canada's Days Sales Outstanding for the quarter that ended in Sep. 2015 is calculated as:

	Days Sales Outstanding (Q: Sep. 2015 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2015 )	+	Accounts Receivable (A: Sep. 2015 ))	/	count )	/	Revenue (A: Sep. 2015 )	*	Days in Period
=	( (4.529	+	5.298)	/	2 )	/	6.79	*	365 / 4
=	4.9135					/	6.79	*	365 / 4
=	66.03

Tribute Pharmaceuticals Canada (OTCPK:TBUFF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Tribute Pharmaceuticals Canada Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tribute Pharmaceuticals Canada's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tribute Pharmaceuticals Canada Inc (OTCPK:TBUFF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.stellarpharma.com

Tribute Pharmaceuticals Canada Inc was incorporated under the Business Corporations Act (Ontario) on November 14, 1994. The Company is a specialty pharmaceutical company. It conducts acquisition, licensing, development and promotion of healthcare products in Canada. It sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The Company's portfolio of assets includes nine product lines, eight of which are on the market in Canada, including: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, Collatamp G, and MycoVa. The Company markets its products in Canada through its own sales force and currently has licensing agreements for the distribution of select products in over 20 countries, and continues to expand this footprint. It faces product competition from companies marketing competing pharmaceutical products and medical devices in Canada. The Company's operations are or may be subject to various federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with treating physicians, data protection, safe working conditions, laboratory and manufacturing practices, the export of products to certain countries and the purchase, storage, movement, use and disposal of hazardous or potentially hazardous substances.

Executives

John M Gregory	director, 10 percent owner
Sj Strategic Investments Llc	10 percent owner
Joan P Gregory	other: Member	340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
James M Gregory	other: Member	340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
Susan Gregory	other: Member	340 MARTIN LUTHER KING, JR. BLVD, SUITE 200, BRISTOL TN 37620

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Headlines

No Headlines